Publication | Closed Access
The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma
67
Citations
31
References
2002
Year
Hematological MalignancyOncologyHematologyMyeloid NeoplasiaMedicineRadiation OncologyRelapsed/refractory Multiple MyelomaHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1